文献速递牙周病牙体牙髓病

KLF4在代谢综合征相关牙周炎中性粒细胞衰老中的作用

Role of KLF4 in Neutrophil Aging in Periodontitis with Metabolic Syndrome.
PubMed 文献 · J Dent Res · 2026-03-20

本研究探讨KLF4在代谢综合征(MetS)加剧牙周炎(PD)过程中调控中性粒细胞衰老的作用。临床样本与小鼠模型显示MetS促进衰老中性粒细胞浸润牙周组织并呈现促炎表型,KLF4下调是关键环节;罗格列酮稳定KLF4可减轻牙周损伤并改善胰岛素抵抗,且该效应在Klf4缺陷模型中消失。

要点

  • MetS促进衰老中性粒细胞浸润牙周组织并增强促炎表型。
  • KLF4下调与MetS加剧牙周炎的中性粒细胞衰老相关。
  • 罗格列酮稳定KLF4可减轻小鼠牙周损伤并改善胰岛素抵抗。

核心结论

  • KLF4参与调控中性粒细胞衰老,MetS通过该途径加剧牙周炎,激活KLF4是有前景的治疗策略。

研究设计与样本

  • 研究分析临床人类样本与小鼠模型,并结合生物信息学、体外细胞实验及虚拟对接与分子动力学模拟。

主要发现

  • MetS增强衰老中性粒细胞浸润牙周组织,这些细胞分泌衰老相关分泌表型因子增多、中性粒细胞胞外诱捕网形成增强并向糖酵解代谢重编程。
  • 生物信息学识别KLF4为MetS与PD共病中关键下调基因。
  • 过继转移MetS来源或Klf4缺陷中性粒细胞加重小鼠牙周炎症与牙槽骨破坏。
  • 体外KLF4敲低促进人中性粒细胞样细胞系代谢重编程与促炎表型。
  • 罗格列酮预测可稳定KLF4,减轻小鼠牙周损伤并改善胰岛素抵抗,该治疗效应在Klf4缺陷模型中被消除。

临床怎么用

  • KLF4激活可能作为MetS相关牙周炎的治疗靶点,罗格列酮为候选化合物但需进一步临床验证。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Metabolic syndrome (MetS) and periodontitis (PD) are major interconnected health burdens, and the inflammatory interplay between them remains elusive. Neutrophils, central to periodontal immunity, can undergo functional alterations contributing to disease exacerbation. This study investigates the role of Krüppel-like factor 4 (KLF4) in regulating neutrophil aging during the exacerbation of PD by MetS. The analysis of clinical human samples and murine models revealed that MetS enhances the infiltration of senescent neutrophils into periodontal tissues. These neutrophils exhibit a heightened proinflammatory phenotype, including increased secretion of senescence-associated secretory phenotype factors, enhanced formation of neutrophil extracellular traps, and a metabolic reprogramming toward a glycolytic shift. Bioinformatics identified KLF4 as a key downregulated gene in comorbid MetS and PD. Adoptive transfer of MetS-derived or Klf4-deficient neutrophils into mice with periodontitis aggravated periodontal inflammation and alveolar bone destruction. In vitro, KLF4 knockdown in human neutrophil-like cell lines promoted metabolic reprogramming and proinflammatory phenotype. Through virtual docking and molecular dynamics simulations, we identified rosiglitazone as a candidate compound predicted to stabilize KLF4. This compound alleviated periodontal damage and improved insulin resistance in mice by mitigating the neutrophil aging phenotype and suppressing proinflammatory responses. Critically, all of these therapeutic effects were abolished in Klf4-deficient models. These results indicate that KLF4 is associated with the regulation of neutrophil aging through which MetS exacerbates periodontitis, highlighting KLF4 activation as a promising therapeutic strategy.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Li C, Zhou Y, Gou H, et al. Role of KLF4 in Neutrophil Aging in Periodontitis with Metabolic Syndrome. J Dent Res. 2026. PMID: 41863084. doi:10.1177/00220345261429954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。